GENEVA, June 12 -- SYSTIMMUNE, INC. (15318 NE 95th StRedmond, Washington 98052) filed a patent application (PCT/US2024/057935) for "BISPECIFIC TETRAVALENT ANTIBODY TARGETING HER2 AND HER3" on Nov 28, 2024. With publication no. WO/2025/117871, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RENSHAW, Blair (16210 SE 166th Ct,Renton, Washington 98058), ZHU, Yi (15318 NE 95th StRedmond, Washington 98052)

Abstract: Anti-HER2 X HER3 bispecific tetravalent antibodies are configured to have two heavy chains and two light chain...